salmeterol xinafoate has been researched along with Bronchial Hyperreactivity in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (41.18) | 18.2507 |
| 2000's | 18 (52.94) | 29.6817 |
| 2010's | 2 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duiverman, AE; Hop, WC; Jongste, JC; Nuijsink, M; Sterk, PJ | 1 |
| Couriel, J; Evans, HJ; Halfhide, C | 2 |
| Bratke, K; Edner, A; Kuepper, M; Lindner, Y; Lommatzsch, M; Virchow, JC | 1 |
| Abel, P; Evans, J; Gendapodi, PR; Qutna, N; Romero, FA; Townley, RG | 1 |
| Page, C | 1 |
| Aalbers, R; van der Woude, HJ | 1 |
| Fukkuda, T | 1 |
| Barazzone-Argiroffo, C; Habre, W; Peták, F; Schütz, N; Sly, PD | 1 |
| Pourazar, J; Sandström, T; Wallin, A | 1 |
| Currie, GP; Lee, DK | 1 |
| de Jongste, JC; Hoogsteden, HC; Leman, K; Mulder, PG; Overbeek, SE; Prins, JB; van den Toorn, LM | 1 |
| Berg-Smith, SM; Kemeny, ME; Kline, JN; Panettieri, RA; Rose, RM; Rosenwasser, LJ | 1 |
| de Jongste, JC; Duiverman, EJ; Hop, WC; Nuijsink, M; Sterk, PJ | 1 |
| Liu, CT; Pang, YM; Tan, CW; Wang, G; Wang, YM | 1 |
| Andersen, L; Dorinsky, P; Koenig, SM; Murray, JJ; Prillaman, B; Stauffer, J; Wolfe, J; Yancey, S | 1 |
| Bos, AB; Hop, WC; Kerrebijn, KF; Verberne, AA | 1 |
| Lötvall, J; Svedmyr, N | 1 |
| Jacques, LA; Lundback, B; Ringdal, N; Woolcock, A | 1 |
| Chazan, R; Droszcz, W; Grubek-Jaworska, H; Jaworski, A | 1 |
| Dottorini, ML; Grassi, V; Peccini, F; Sorbini, CA; Tantucci, C | 1 |
| Adachi, M; Horikoshi, S; Kokubu, F | 1 |
| Douma, RR; Koëter, GH; Postma, DS; Weersink, EJ | 1 |
| Lipworth, BJ | 1 |
| Barnes, PJ; Worsdell, M; Yates, DH | 1 |
| Simons, FE | 1 |
| Baker, JW; Busse, WW; Emmett, A; Kalberg, C; Kemp, JP; Rickard, KA; Rosenthal, RR | 1 |
| de Jongste, JC; Verberne, AA | 1 |
| Bisgaard, H | 1 |
| Dempsey, OJ; Lipworth, BJ; Mistry, C; Sims, EJ; Wilson, AM | 1 |
| Calhoun, WJ; Hinton, KL; Kratzenberg, JJ | 1 |
| Adachi, M; Choudry, NB; Fuller, RW; O'Shaughnessy, KM; Palmer, JB; Taylor, IK | 1 |
| Boulet, LP | 1 |
| Adachi, M; Kokubu, F; Takahashi, S | 1 |
10 review(s) available for salmeterol xinafoate and Bronchial Hyperreactivity
| Article | Year |
|---|---|
WITHDRAWN: Inhaled bronchodilators for cystic fibrosis.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchial Hyperreactivity; Bronchodilator Agents; Child; Cystic Fibrosis; Humans; Ipratropium; Randomized Controlled Trials as Topic; Salmeterol Xinafoate | 2016 |
Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Dose-Response Relationship, Drug; Ethanolamines; Formoterol Fumarate; Humans; Mast Cells; Nebulizers and Vaporizers; Salmeterol Xinafoate | 2002 |
[Recent study on pathogenesis of bronchial asthma and the therapeutic strategy].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchi; Bronchial Diseases; Bronchial Hyperreactivity; Bronchitis; Constriction, Pathologic; Drug Therapy, Combination; Eosinophilia; Glucocorticoids; Humans; Salmeterol Xinafoate; Theophylline | 2004 |
Inhaled bronchodilators for cystic fibrosis.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchial Hyperreactivity; Bronchodilator Agents; Child; Cystic Fibrosis; Humans; Ipratropium; Randomized Controlled Trials as Topic; Salmeterol Xinafoate | 2005 |
Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchodilator Agents; Clinical Trials as Topic; Humans; Lung Volume Measurements; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 1993 |
[Anti-allergic effects of beta-adrenoceptor agonists in the clinical pharmacological studies].
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Allergic Agents; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchial Provocation Tests; Humans; In Vitro Techniques; Inflammation Mediators; Intercellular Adhesion Molecule-1; Leukotriene E4; Mast Cells; Procaterol; Salmeterol Xinafoate | 1996 |
Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Bronchodilator Agents; Down-Regulation; Ethanolamines; Formoterol Fumarate; Humans; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 1997 |
Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
Topics: Administration, Topical; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Asthma, Exercise-Induced; Bronchi; Bronchial Hyperreactivity; Bronchodilator Agents; Child; Double-Blind Method; Drug Combinations; Drug Tolerance; Ethanolamines; Formoterol Fumarate; Glucocorticoids; Humans; Lung; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Status Asthmaticus | 2000 |
[Bronchodilator effect of salmeterol and inhibition of bronchial hyperreactivity].
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Clinical Trials as Topic; Humans; Methacholine Chloride; Salmeterol Xinafoate; Time Factors | 1992 |
[Variety of pharmacological action of beta agonists].
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cyclic AMP; Ethanolamines; Humans; Procaterol; Receptors, Adrenergic, beta; Salmeterol Xinafoate | 1992 |
18 trial(s) available for salmeterol xinafoate and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Perception of bronchoconstriction: a complementary disease marker in children with asthma.
Topics: Adolescent; Albuterol; Androstadienes; Anti-Allergic Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Child; Dyspnea; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Perception; Salmeterol Xinafoate | 2013 |
Adverse effects of salmeterol in asthma: a neuronal perspective.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Asthma; Brain-Derived Neurotrophic Factor; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Histamine; Humans; Leukocytes, Mononuclear; Male; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Young Adult | 2009 |
LPS-induced bronchoalveolar neutrophilia; effects of salmeterol treatment.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lipopolysaccharides; Male; Neutrophils; Salmeterol Xinafoate | 2004 |
Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.
Topics: Adolescent; Adult; Albuterol; Analysis of Variance; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Breath Tests; Bronchial Hyperreactivity; Bronchoscopy; Double-Blind Method; Female; Fluticasone; Humans; Male; Nebulizers and Vaporizers; Nitric Oxide; Respiratory Function Tests; Salmeterol Xinafoate; Treatment Outcome | 2005 |
Placebo response in asthma: a robust and objective phenomenon.
Topics: Adolescent; Adult; Albuterol; Asthma; Bronchial Hyperreactivity; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Physician's Role; Placebo Effect; Placebos; Predictive Value of Tests; Salmeterol Xinafoate; Single-Blind Method | 2007 |
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial.
Topics: Administration, Inhalation; Adolescent; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Salmeterol Xinafoate; Treatment Outcome | 2007 |
[A clinical study on the significance of airway hyperresponsiveness monitoring in the adjustment of combined therapy for asthmatic patients].
Topics: Adolescent; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Middle Aged; Respiratory Function Tests; Salmeterol Xinafoate; Young Adult | 2007 |
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Area Under Curve; Asthma; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Bronchodilator Agents; Child; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Humans; Latin America; Latvia; Male; Metered Dose Inhalers; Methacholine Chloride; Middle Aged; Patient Selection; Practice Guidelines as Topic; Salmeterol Xinafoate; Treatment Outcome; United States | 2008 |
Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Bronchodilator Agents; Child; Double-Blind Method; Female; Humans; Male; Methacholine Chloride; Respiratory Function Tests; Salmeterol Xinafoate; Survival Analysis | 1993 |
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Histamine; Humans; Lung; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate | 1996 |
Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Asthma; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Bronchodilator Agents; Circadian Rhythm; Drug Interactions; Female; Humans; Male; Methacholine Chloride; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate | 1996 |
Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Circadian Rhythm; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Glucocorticoids; Humans; Male; Methacholine Chloride; Salmeterol Xinafoate | 1997 |
Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Salmeterol Xinafoate | 1997 |
A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Beclomethasone; Bronchial Hyperreactivity; Bronchodilator Agents; Child; Double-Blind Method; Female; Glucocorticoids; Growth; Humans; Male; Placebos; Pulmonary Ventilation; Salmeterol Xinafoate | 1997 |
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aerosols; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Peak Expiratory Flow Rate; Salmeterol Xinafoate | 1999 |
Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Leukotriene Antagonists; Quinolines; Respiratory Function Tests; Salmeterol Xinafoate; Single-Blind Method; Sulfides; Treatment Outcome | 2000 |
The effect of salmeterol on markers of airway inflammation following segmental allergen challenge.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Allergens; Analysis of Variance; Asthma; Biomarkers; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Pneumonia; Probability; Reference Values; Respiratory Function Tests; Salmeterol Xinafoate; Treatment Outcome | 2001 |
A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion.
Topics: Adrenergic beta-Agonists; Albuterol; Allergens; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Double-Blind Method; Humans; Hypersensitivity, Immediate; Leukotriene E4; Salmeterol Xinafoate; SRS-A; Time Factors | 1992 |
6 other study(ies) available for salmeterol xinafoate and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Animals; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Interleukin-13; Interleukin-13 Receptor alpha2 Subunit; Methacholine Chloride; Mice; Mice, Inbred BALB C; Ovalbumin; Salmeterol Xinafoate | 2009 |
The beta2 receptor and airway hyper-responsiveness: are sensory nerves involved?
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Humans; Neurons, Afferent; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 2009 |
Prevention of bronchoconstriction in sensitized guinea pigs: efficacy of common prophylactic drugs.
Topics: Adrenergic Agonists; Adrenergic beta-2 Receptor Agonists; Albuterol; Allergens; Analysis of Variance; Androstadienes; Animals; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Cholinergic Antagonists; Cromolyn Sodium; Dose-Response Relationship, Drug; Drug Interactions; Fluticasone; Guinea Pigs; Histamine; Histamine H1 Antagonists; Ipratropium; Male; Methacholine Chloride; Ovalbumin; Salmeterol Xinafoate | 2004 |
The GOAL study: designed to favor a long-acting beta2-agonist?
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Drug Therapy, Combination; Fluticasone; Humans; Inflammation; Research Design; Salmeterol Xinafoate; Treatment Outcome | 2005 |
[Effect of 16-week use of salmeterol on ECP levels, pulmonary function tests and bronchial hyperreactivity in patients with chronic obstructive lung disease].
Topics: Albuterol; Blood Proteins; Bronchial Hyperreactivity; Bronchodilator Agents; Eosinophil Granule Proteins; Forced Expiratory Volume; Humans; Inflammation Mediators; Lung Diseases, Obstructive; Middle Aged; Respiratory Function Tests; Ribonucleases; Salmeterol Xinafoate; Sputum | 1995 |
Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet)
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchitis; Bronchodilator Agents; Child; Eosinophilia; Ethanolamines; Formoterol Fumarate; Humans; Lung; Salmeterol Xinafoate | 2000 |